TWO CORE TECHNOLOGIES.
MORE PRECISE MEDICINE.
Auransa’s innovative approach to developing precise medicine for patients is based on two core proprietary technologies developed over the past four years.
SMarTR™ Engine is an artificial intelligence (AI)-driven platform for discovering patient subpopulations, novel targets, unique mechanisms of action and precise therapies.
CTSeek™ Liquid Biopsy is a companion liquid biopsy technology that will ensure we are identifying the appropriate patients for our clinical trials and enable us to monitor their responses to our treatments.